Combined therapy of tofacitinib plus iguratimod improves rheumatoid arthritis-usual interstitial pneumonia
GLORIA trial findings show the safety and tolerability of tapering glucocorticoids in elderly RA patients
Phases IIa trial reports that tildrakizumab treatment did not improve ASAS20 response rate in ankylosing spondylitis patients
